PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
20-May-2022 Evox Therapeutics Announces Data Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting Evox Therapeutics
20-May-2022 Calliditas receives positive CHMP opinion in IgA nephropathy Calliditas Therapeutics AB
20-May-2022 Astellas Analysis Shows No Evidence of Increased Risk of Cardiovascular Events or Mortality with Roxadustat Compared with Erythropoiesis-Stimulating Agents (ESAs) at 59th ERA Congress 2022 Astellas Pharma Inc.
20-May-2022 World-renowned Health Experts to gather in London at Integrative and Personalised Medicine 2022 Congress Integrative and Personalised Medicine 2022
20-May-2022 OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing OKYO Pharma Limited
20-May-2022 OKYO Pharma Limited - PDMR Dealing OKYO Pharma Limited
20-May-2022 Birmingham research brings hope for spinal cord injury treatment University of Birmingham
20-May-2022 Astellas Analysis Shows No Evidence of Increased Risk of Cardiovascular Events or Mortality with Roxadustat Compared with Erythropoiesis-Stimulating Agents (ESAs) at 59th ERA Congress 2022 Astellas Pharma Inc.
20-May-2022 Saba Yussouf, INVISI CEO signs $16 million distribution deal with global distribution firm. Invisi Smart Technologies UK Limited
20-May-2022 Chiesi acquires therapeutic monoclonal antibodies portfolio being investigated as potential treatment for pulmonary arterial hypertension Chiesi Farmaceutici S.p.A.
20-May-2022 Procysbi® (mercaptamine bitartrate gastro-resistant hard capsules) recommended for use within NHS Wales as an option for the treatment of patients with nephropathic cystinosis Chiesi Limited
20-May-2022 ASLAN PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF LATE-BREAKING ABSTRACT ON EBLASAKIMAB AND NEURONAL ITCH MECHANISMS FOR POSTER PRESENTATION AT THE 2022 SOCIETY FOR INVESTIGATIVE DERMATOLOGY ANNUAL MEETING ASLAN Pharmaceuticals
20-May-2022 People with bladder cancer feel disadvantaged by their cancer, according to new report1 Astellas Pharma Inc
20-May-2022 US FDA accepts Cytovation's IND application for Phase II combination studies of CyPep-1, a first-in-class targeted tumor membrane immunotherapy Cytovation ASA
20-May-2022 Solvay extends its sustainable polymer offering for smart devices and wearables Solvay
20-May-2022 Weekly Life Science News Round Up: 16th – 20th May PharmiWeb.Jobs
20-May-2022 Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report Gilead
20-May-2022 Douglas GmbH: Release of results for the second quarter and first half year 2021/22 (ending 31 March 2022) on 25 May 2022 Douglas GmbH
20-May-2022 Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe Straumann Holding AG
19-May-2022 Medacta Group announces the results of today's Annual General Meeting Medacta Group SA